Standardutveckling · SIS/TK 620

Genomik och precisionsmedicin

Standardisering inom genomik och precisionsmedicin är avgörande för att genetiska data ska kunna delas, tolkas och användas på ett säkert och jämförbart sätt mellan olika vårdgivare och laboratorier. Gemensamma standarder stärker kvaliteten och inter-operabiliteten, vilket skapar förutsättningar för mer träffsäkra diagnoser, individanpassade behandlingar och effektiv forskning.

Området kommittén arbetar med är relativt nytt inom den svenska, europeiska och internationella standardiseringen (SIS, CEN och ISO) och genom att delta i kommittén kan du vara med och påverka utvecklingen av framtida standarder inom genomik och precisionsmedicin. Standarderna bidrar till ökad kvalitet, interoperabilitet och tillförlitlighet inom området.

 

Kommittén skapar ett forum för svenskt agerande i den internationella standardiseringen, genom att vi aktivt medverkar i den internationella standardiseringsorganisationen  ISO genom ISO/TC 276 Biotechnology,    ISO/TC 276/SC 1 Analytical Methods, ISO/TC 276/SC 2 Microphysiological Systems and Organ-on-Chip och ISO/TC 215/SC 1 Genomics Informatics

 

Alla organisationer som arbetar inom områdena är välkomna att delta i arbetet och får därmed vara del av den internationella standardiseringen inom genomik, precisionsmedicin samt de som arbetar med organ on chip.

 

Vill du veta mer eller delta i standardiseringsarbetet inom området är du välkommen att kontakta projektledningen för mer information,

 

 

 

Mer information om kommitténs arbete:

Verksamhetsplan
Arbetar nu med 83 standarder
ISO/FDIS 23494-3, Biotechnology — Provenance information model for biological material and data — Part 3: Provenance of biological material (50.20)
ISO/FDIS 24031, Biotechnology — General requirements for nucleic acid- and protein-based bio-devices (50.20)
ISO/FDIS 25347, Biotechnology — Bioprocessing — General requirements for the purification of extracellular vesicles (50.00)
ISO/DIS 22692, Genomics informatics — Quality control metrics for DNA sequencing (40.60)
ISO/DIS 23565, Biotechnology — Bioprocessing — General requirements and considerations for equipment systems used in the manufacturing of cellular therapeutic products (40.60)
ISO/DIS 24934, Genomics informatics — Multi-omics quality control and data integration (40.60)
ISO/DIS 24088-1, Biotechnology — Biobanking of microorganisms — Part 1: Bacteria and archaea (40.20)
ISO/DIS 24603, Biotechnology — Biobanking — Requirements for human and mouse pluripotent stem cells (40.20)
ISO/DIS 25383, Biotechnology — Single cell sequencing — Part 1: Requirements for data processing of RNA-sequencing for eukaryotic cells (40.20)
ISO/DIS 25448, Microphysiological systems and Organ-on-Chip — Vocabulary (40.20)
ISO/DIS 25802, Biotechnology — Requirements for the production and quality control of immunomagnetic beads (40.20)
ISO/DIS 18209-1, Biotechnology — Biobanking of parasites — Part 1: Helminths (40.20)
ISO/DIS 21709, Biotechnology — Biobanking — Process and quality requirements for establishment, maintenance and characterization of mammalian cell lines (40.20)
ISO/DIS 21973, Biotechnology — General requirements for transportation of cellular therapeutic products (40.00)
ISO/DIS 8472-3, Biotechnology — Data interoperability for stem cell data — Part 3: Schema of the database structure (40.00)
ISO/CD 21710, Biotechnology — Specification on data management and publication in microbial resource centers (30.99)
ISO/CD 16921-3, Biotechnology — Gene delivery systems — Part 3: Methods for the quantification and characterization of lipid nanoparticles (30.60)
ISO/CD 20395.2, Biotechnology — Requirements for evaluating the performance of quantification methods for nucleic acid target sequences — qPCR and dPCR (30.60)
ISO/CD 20399-4, Biotechnology — Ancillary materials present during the production of cellular therapeutic products and gene therapy products — Part 4: Requirements for the certificate of analysis and the certificate of origin (30.60)
ISO/CD 25430-1, Biotechnology — Organoids — Part 1: Vocabulary and naming convention (30.60)
ISO/CD 25430-2, Biotechnology — Organoids — Part 2: Manufacturing and quality control of human organoids (30.60)
ISO/CD 25430-3, Biotechnology — Organoids — Part 3: Endpoint quality assessment of human intestinal organoids (30.60)
ISO/CD 25430-4, Biotechnology — Organoids — Part 4: Endpoint quality assessment of human liver organoids derived from pluripotent stem cells (30.60)
ISO/CD 25530, Microphysiological systems and Organ-on-Chip — Quality control and documentation for cellular components (30.60)
ISO/CD 25591, Microphysiological systems and Organ-on-Chip — Digital twins and computational modelling (30.60)
ISO/CD 25693, Microphysiological systems and Organ-on-Chip — Developing process of Organ-on-Chip used for the evaluation of substances (30.60)
ISO/CD 25746, Biotechnology — Bioprocessing — General requirements and considerations for processing decellularized extracellular matrices of soft tissues (30.60)
ISO/CD 8934-2, Biotechnology --Cell viability analytical methods — Part 2: Experimental Designs and Statistical Analysis for Evaluating the Quality of Cell Count-Based Viability Methods (30.60)
ISO/CD TS 25812, Biotechnology — General requirements for performance evaluation of hydrogel materials used in bio-device fabrication (30.20)
IEC/CD TR 63719-1, Medical devices – In silico technologies — Part 1: Terminology and context (30.00)
ISO/WD 26013, Biotechnology — Bioprinting — Requirements for the printing process (20.60)
ISO/WD 12833, Biotechnology — Requirements for RNA quantification methods for gene expression analysis of biological and bioengineered systems (20.60)
ISO/WD 25289, Microphysiological systems and Organ-on-Chip — Key components and minimum requirements for the model of bronchial microphysiological systems (20.60)
ISO/WD 25824, General requirements and considerations for cell-mediated cytotoxicity assays used in characterization and testing of CAR products for therapeutic use (20.20)
ISO/WD 26086, Microphysiological systems and Organ-on-Chip — Guidance for Flow Control (20.20)
ISO/WD 26125-1.2, Biotechnology — Tumorigenicity testing — Part 1: General requirements and considerations for testing of cellular therapeutic products (20.20)
ISO/AWI TS 26899, Biotechnology — In vitro cell culture examinations — Requirements for the application of human plasma to cell models (20.00)
ISO/AWI 5058-1, Biotechnology — Genome editing — Part 1: Vocabulary (20.00)
ISO/AWI TR 26485, Genomics Informatics - Case studies on precision medicine with AI (20.00)
ISO/AWI 26077, Genomics Informatics — General Requirements for Pathogen Genome Reference Database (20.00)
IEC/AWI 63719-2, Medical devices — In silico technologies — Part 2: Credibility assessment of first-principles based methods (20.00)
ISO/AWI 25999, Biotechnology — Search API (Application Programming Interface) for discovery of human biological material and associated data in international biobank networks (20.00)
ISO/AWI 26012, General Requirements and Considerations for AAV Capsid Content Characterization for Gene Therapy (20.00)
ISO/AWI 23494-4, Biotechnology — Provenance information model for biological material and data — Part 4: Provenance of data generation (20.00)
ISO/AWI 20397-1, Biotechnology — NGS — Part 1: Nucleic acid and library preparation (10.99)
ISO/AWI 20397-2, Biotechnology — NGS — Part 2: Quality evaluation of sequencing data (10.99)
ISO/AWI 20397-3, Biotechnology — NGS — Part 3: General requirements and guidance for metagenomics (10.99)
ISO/AWI 22860.3, Biotechnology — Unified Modeling Language (UML) metadata specifications for human mesenchymal stromal cells (10.99)
ISO/AWI 23033-1, Biotechnology – Cell characterization — Part 1: General requirements and considerations for the testing and characterization of cellular therapeutic products (10.99)
ISO/AWI 24866, Biotechnology — Bioprocessing — Information requirements and considerations for single use bag assemblies (10.99)
ISO/AWI 25950, Biotechnology — General considerations and requirements for cryopreservation processes for cellular therapeutic products (10.99)
IEC/AWI 63691-2, Medical devices — In silico technologies — Part 2: Credibility assessment of first-principles based methods (10.99)
ISO/AWI 26032.2, Biotechnology — Nucleic acid-based devices — General requirements for the screening and evaluation of nucleic acid aptamers (10.99)
ISO/AWI 26501, Genomics informatics — Privacy-Preserving Computation on Encrypted Genomic Data using Homomorphic Encryption (10.99)
ISO/AWI 26502, Genomics informatics — Federated Learning Frameworks for Secondary Use of Clinical Genomic Data (10.99)
ISO/AWI 26874-1, Biotechnology — Proteins — Part 1: Terminology (10.99)
ISO/AWI TS 26076, Genomics informatics — General requirements for data elements of peptidomics data (10.99)
ISO/AWI TS 26499, Genomics Informatics — Requirements for data extraction and refinement in AI-assisted precision medicine (10.99)
ISO/NP 25778, Genomics Informatics --Variant QR code in genetic test report (10.60)
ISO/NP 16921-4, Biotechnology — Gene delivery systems — Part 4: General Considerations for Characterization of the Capsid Protein Particle Population in AAV Products (10.60)
ISO/NP 25637.2, Biotechnology — Analytical Methods — Guidelines for the application of whole genome sequencing for genome-wide genetic diversity assessment of higher animals and plants (10.20)
ISO/NP 25848, Biotechnology — Process monitoring in biomanufacturing — Vocabulary (10.20)
ISO/NP 26835-2, Biotechnology — Drug toxicity testing using human organoids — Part 2: Part 2: Quality requirements for human pluripotent stem cell-derived cardiac organoids (10.20)
ISO/PWI 20688-3, Biotechnology — Nucleic acid synthesis — Part 3: Screening requirements for ensuring biosafety and biosecurity (00.00)
ISO/PWI 23033-2, Biotechnology —– Cell characterization — Part 2: General requirements and considerations for the testing and characterization of human and mammalian-derived cells and cell lines (00.00)
ISO/PWI 25779, Pedigree – Common Dataset for Family Health History (00.00)
ISO/PWI 25998, Biotechnology - Nucleic acid-based devices - General requirements for the screening and evaluation of nucleic acid aptamers (00.00)
ISO/PWI 26125-2, Biotechnology Tumorigenicity Testing — Part 2: Nucleic Acid Detection for Undifferentiated Pluripotent Stem Cells in cell and gene therapy products (00.00)
ISO/PWI 26630, Biotechnology — General requirements for bioinformatics database design and construction (00.00)
ISO/PWI 26832, Biotechnology — Bioprocessing — General requirements for one pot multi-enzymatic catalysis (00.00)
ISO/PWI 26833, Biotechnology — Bioprocessing — General requirements and considerations for bioreactor equipment systems used in the manufacturing of cellular therapeutic products (00.00)
ISO/PWI 26834, Biotechnology — Bio-device for data storage — Part 1: Performance evaluation of materials (00.00)
ISO/PWI 26835-1, Biotechnology — Drug toxicity testing using human organoids — Part 1: General requirements and considerations (00.00)
ISO/PWI 26837, Microphysiological systems and Organ-on-Chip — General requirements for multiple tissues linkage microphysiological systems (00.00)
ISO/PWI 26841, Biotechnology — Analytical methods — General requirements and considerations for the characterization for composition of extracellular vesicles (00.00)
ISO/PWI 26853, Genomics informatics — Data analysis requirements for minimal residual disease assessment by adaptive immune receptor sequencing (00.00)
ISO/PWI 26854, Genomics informatics — Data elements and metadata for assessing gut microbiome modulation in human health (00.00)
ISO/PWI 26855, Genomics informatics — Reference material- based quality management for quantitative multi-omics -General principles (00.00)
ISO/PWI 26856, Genomics informatics — Specifications of Quality Control Metrics for Whole Genome Sequencing (00.00)
ISO/PWI 26860, Biotechnology — Cellular morphological analysis — Part 2: General requirements and considerations for three-dimensional characterization of cells and multi-cellular structures by optical microscopy (00.00)
ISO/PWI 26861, Biotechnology — Analytical methods — Development of reference spectra for microbial species identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) (00.00)
ISO/PWI 26863, Method for absolute quantification of RNA-seq using spike-in reference materials with metrological traceability to the SI (00.00)
ISO/PWI 63691-2, Medical devices — In silico technologies — Part 2: Credibility assessment of first-principles based methods (00.00)
Visa fler Visa färre
Utgivet 3 standarder
Deltagare 5 företag och organisationer
Karolinska Institutet, Stockholm
Oncodia AB, Uppsala
QuTEM AB, Stockholm
Region Stockholm, Stockholm
RISE Research Institutes of Sweden AB, Borås
Visa fler Visa färre
Internationellt deltagande 8 internationella kommittéer
ISO/TC 215/SC 1, Genomics and Multi-Omics Informatics
ISO/TC 215/SC 1/WG 1, Genomics data sharing
ISO/TC 276, Biotechnology
ISO/TC 276/SC 1, Analytical methods
ISO/TC 276/SC 1/WG 1, Gene delivery
ISO/TC 276/SC 2, Microphysiological systems and Organ-on-Chip
ISO/TC 276/WG 4, Bioprocessing for cells and related entities
ISO/TC 276/WG 5, Data processing and integration
Visa fler Visa färre
Finansiering

Deltagande i standardiseringsarbete inbegriper en deltagaravgift. Läs mer här om hur arbetet finansieras och vilka avgifter som gäller för olika typer av organisationer.


Intresseanmälan

Jag vill gärna veta mer om kommitténs arbete.

För dig som är kommittédeltagare

Klicka här för att ta dig till kommitténs digitala arbetsyta och röstningsportal.

Kommittén bidrar bland annat till de här tre målen: 

sdg3.png
sdg9.png
sdg10.png

Läs mer om de globala målen här >

Följ oss på vår LinkedIn, Hälsa, vård och omsorg SIS

Kontakt

Har du frågor eller vill veta mer om SIS standardiseringsverksamhet? Kontakta gärna oss.

Hanna Dumky
Projektledare
hanna.dumky@sis.se

Mattis Rundgren
Projektkoordinator
mattis.rundgren@sis.se